Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time
The Use of Ketamine Versus Methohexital for Electroconvulsive Therapy: A Cross-Over Comparative Study on Patient Recovery and Re-Orientation Time
1 other identifier
interventional
20
1 country
1
Brief Summary
When undergoing ECT treatments, patient recovery time and re-orientation time may be shorter using ketamine for induction than using methohexital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 28, 2012
CompletedFirst Posted
Study publicly available on registry
March 30, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedResults Posted
Study results publicly available
December 30, 2014
CompletedDecember 30, 2014
June 1, 2014
1.6 years
March 28, 2012
May 21, 2014
December 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Re-orientation Time
Patients will be scored based on 5 questions (name, age, year, day of week, location). Each patient will be scored prior to induction as to how many questions they score correctly. Patient is deemed re-oriented when they score the same as baseline after the treatment.
1 hour
Recovery Time
Recovery was assessed using 5 criteria (blood pressure, voluntary movement, oxygen requirement, consciousness, respiratory effort). Each criteria was scored from 0-2, with a full score of 10. The patient is scored at baseline, and is deemed recovered when all criteria has reached baseline score again.
1 hour
Study Arms (2)
Ketamine First
EXPERIMENTALThis arm will receive ketamine for induction first, followed by alternating treatments between methohexital and ketamine
Methohexital First
EXPERIMENTALThis arm will receive Methohexital first for induction, followed by alternating treatments between ketamine and methohexital.
Interventions
Ketamine (1.5mg/kg) will be given for induction, with room to titrate up to induction effect
Eligibility Criteria
You may qualify if:
- All patients eligible for ECT with a primary mood disorder (bipolar disorder, major depressive disorder) will be eligible to participate in this study. - Patients must have decisional capacity and must be able to consent for this study.
You may not qualify if:
- patients with a primary psychotic disorder (schizophrenia, schizoaffective disorder); patients designated as having an American Society of Anesthesiologist (ASA) Status of greater than 3;
- patients with a known allergic reactions to methohexital , ketamine and succinylcholine;
- patients with current or previous history of aneurysms, intracranial bleeds, or intracranial hypertension;
- patients with uncontrolled severe hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of New Mexico
Albuquerque, New Mexico, 87131, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Tony Yen
- Organization
- University of NewMexico
Study Officials
- PRINCIPAL INVESTIGATOR
Tony Yen, MD
University of New Mexico
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2012
First Posted
March 30, 2012
Study Start
August 1, 2011
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
December 30, 2014
Results First Posted
December 30, 2014
Record last verified: 2014-06